Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

134.92 +1.75 (+1.31%)
Official Closing Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
42 43 Next >
Abbott Laboratories Whale Trades For October 06
A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 10 strange trades. 
Via Benzinga
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500. 
Via InvestorPlace
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.74% on an annualized basis producing an average annual return of 11.68%. Currently, Abbott Laboratories has a... 
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Azure, Abbott, TuSimple, and Kohl’s and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over. 
Via InvestorPlace
ABT INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
WHY: New York, NY - (NewMediaWire) - September 26, 2022 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19,... 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Awakn And Catalent's Partnership Could Provide Hope For People Suffering From Addiction
Since 2020, Awakn Life Sciences Corp. (OTCQB: AWKNF) reports that it has been researching, developing and commercializing therapeu 
Via Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 7.32% since its last report. The company recently reported that it has 12.94 million shares sold short, which is 0.76% of all regular... 
Via Benzinga
NATIONALLY RANKED ROSEN LAW FIRM Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.57% on an annualized basis producing an average annual return of 11.72%. Currently, Abbott Laboratories has a... 
Via Benzinga
FDA Concludes Oversight Shortcomings After Infant Formula Internal Review
The FDA concluded an internal review of agency actions related to the U.S. infant formula supply. 
Via Benzinga
5 Dividend Growth Stocks That Have Totally Collapsed
Today, I want to tell you about 5 dividend growth stocks that are down more than 20% from their recent highs. 
Via Talk Markets
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read. 
Via Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Abbott Laboratories (NYSE:ABT) Shareholder Notice: Lawsuit Alleges Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 09/13/2022 -- An investor, who purchased shares of Abbott Laboratories (NYSE:ABT), filed a lawsuit over alleged Securities Laws violations by Abbott Laboratories in... 
Via SBWire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Dividend Income Update August 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Top Financial Stories Friday, September 09: Elon Musk Hints At Potential Apple-SpaceX Partnership, GM's EV For Cost Conscious Buyers, Google Under DOJ Scanner For Search-Engine Dominance And More...
Bloomberg When The Bank Error Is Not In Your Favor: Pay Back $500 Million 
Via Benzinga
FDA Warns of Clip Lock Malfunctions With Abbott's MitraClip Heart Valve Devices
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABT
From The Rosen Law Firm, P.A.
Via Business Wire
ABBOTT LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
From Kahn Swick & Foti, LLC
Via Business Wire
ABBOTT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Inquire About Class Action Investigation – ABT
From The Rosen Law Firm, P.A.
Via Business Wire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.